Myoblast city (Mbc) is a guanine nucleotide exchange factor (GEF)–like protein in the fruit fly Drosophila melanogaster and is the ortholog of the mammalian Dock180 protein. Mbc activates the small GTPase Rac1 to regulate actin cytoskeleton remodeling during development. The gene was first identified through deletion mapping on the right arm of chromosome 3, where multiple lethal recessive alleles revealed its essential developmental role. Mbc is required for several morphogenetic processes, including myoblast fusion, dorsal closure, and axon guidance, and embryos lacking functional Mbc display severe defects in muscle formation and epithelial morphogenesis. Mutated mbc embryos exhibit defects particularly in dorsal closure, cytoskeletal organization, myogenesis, and neural development.
Discovery The Myoblast city locus was identified by deletion mapping; using this technique, researchers were able to isolate the location of the gene on the right arm of the third chromosome. During the process four recessive alleles of Mbc were found; mbcc1, mbcc2, mbcc3, mbcs4, all of which are lethal and the D. melanogaster embryos fail to hatch. During the first 9–10 hours of development, embryos with the mutant Mbc alleles show the same myosin expression as wild-type embryos. However, at about the 11th hour, most myoblasts fail to fuse. As development progresses, some myoblasts show signs of fusion, such as elongation and having multiple nuclei; but some remain round. After 13–14 hours of development, most cells in mutant embryos that failed to fuse lose myosin expression. Further genetic interactions studies with know fusion regulators placed Mbc downstream of cell adhesion cues but upstream of actin assembly factors. Complementation test confirmed that the lethal phenotypes arise specifically from loss of Mbc function rather than secondary mutation of nearby loci. Molecular cloning of Mbc later validated its identity as the fly homolog of Dock180, demonstrating strong evolutionary conservation.
Gene In Drosophila melanogaster, myoblast city (mbc) is a gene located on the right arm of chromosome 3 in the region 95A–95BC. The gene covers several tens of kilobases and produces multiple transcript variants (such as mbc-RA and mbc-RB) through alternative splicing. It is switched on in the embryo and is expressed in mesoderm-derived tissues and other epithelial tissues that undergo major shape changes during development.
Structure Myoblast city is a large cytoplasmic protein belonging to the conserved CED-5/Dock180 family of Rac guanine nucleotide exchange factors. Mbc contains two signature Dock homology regions, DHR-1 and DHR-2. DHR-1- contributes to membrane association and phospholipid binding, DHR-2- acts as the catalytic domain that activates Rac GTPases and drives actin cytoskeleton remodeling. Mbc forms signaling complexes with several proteins, most notably the ELMO (CED-12) protein, creating an evolutionarily conserved ELMO–Dock complex that promotes Rac recruitment and activation at the plasma membrane. It also interacts with adaptor proteins like Crk and works directly with Rac1 to regulate cell migration, myoblast fusion, and morphogenesis. Homologous proteins are found across metazoans, with the mammalian ortholog Dock180/DOCK1 sharing similar domains and functions. Due to this strong conservation, Mbc serves as an important model for understanding Rac-dependent cytoskeletal regulation in both invertebrates and vertebrates.
Expression pattern Expression of Mbc begins early in the somatic mesoderm during the stages in which myoblast fusion occurs. As development progresses, expression appears in epithelial tissues while undergoing important morphogenetic events, such as the dorsal epidermis and tracheal epithelium. Mbc is also expressed in embryonic hemocyte, where it influences their migration patterns. Low-level expression persists even in certain larval tissues that undergo remodeling or cell migration.
Muscle development During embryonic muscle development, myoblasts undergo a highly regulated fusion process that forms multinucleated muscle fibers. This occurs through a series of steps, including recognition and adhesion between founder cells and fusion-competent myoblasts, formation of an actin-rich focus at the fusion site, pore formation, and cytoplasmic mixing. In Drosophila embryonic muscle development, myoblast fusion occurs between two distinct cell types, founder cells and fusion-competent myoblasts (FCMs). Founder cells specify each muscle fiber's characteristics and initiate fusion, while FCMs adopt the founder cell's identity after fusing. Fusion is inherently asymmetric. The first fusion happens between one founder cell and a single FCM, then between the growing multinucleated muscle precursor and additional FCMs. Specific immunoglobulin superfamily (IgSF) proteins mediate cell recognition since founder cells require Kirre or Rst, while FCMs express Sns or Hbs. Their interactions ensure fusion occurs only between appropriate partners. At fusion sites, dynamic F-actin foci form and disappear just before fusion. These structures depend on actin-polymerizing complexes such as SCAR, WASp, and Arp2/3. The surface receptors cluster into a ring-like adhesion structure around the actin core called the FuRMAS. Among intracellular regulators, the Mbc–Elmo complex, a conserved guanine nucleotide exchange factor (GEF), activates Rac1, a small GTPase essential for cytoskeletal remodeling. Although previously thought to function in both cell types, new findings show that Mbc is required only in FCMs, not founder cells. Active Rac1 and Mbc accumulate at the FCM–founder cell contact site, which correlates with actin enrichment. New findings also suggest that FCMs generate actin-rich protrusions that invade the founder cell prior to fusion. Mbc promotes the formation and organization of F-actin foci through Rac1 activation, making it essential for proper cytoskeletal rearrangement in FCMs. Mutant mbc embryos show a severe failure of myoblasts to fuse, leading to abnormal numbers of mononucleated cells and disrupted muscle patterning.
… excerpt ends here. Continue reading the full article.
